Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL.
Saved in:
| Title: | Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL. |
|---|---|
| Authors: | Ermann DA; Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA. daniel.ermann@hci.utah.edu., Stephens DM; University of North Carolina School of Medicine, Chapel Hill, NC, USA., Wang X; BeOne Medicines, Ltd, San Carlos, CA, USA., Varghese I; ADVI Health, Washington, DC, USA., De Souza H; ADVI Health, Washington, DC, USA., Sheetz C; ADVI Health, Washington, DC, USA., Fu Q; BeOne Medicines, Ltd, San Carlos, CA, USA., Maglinte GA; BeOne Medicines, Ltd, San Carlos, CA, USA., Williams R; BeOne Medicines, Ltd, San Carlos, CA, USA., Seymour EK; BeOne Medicines, Ltd, San Carlos, CA, USA., van Beuge D; BeOne Medicines, Ltd, San Carlos, CA, USA., Shadman M; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA., Jacobs R; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA. |
| Source: | Oncology and therapy [Oncol Ther] 2026 Jun 22. Date of Electronic Publication: 2026 Jun 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis Country of Publication: New Zealand NLM ID: 101677510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2366-1089 (Electronic) Linking ISSN: 23661089 NLM ISO Abbreviation: Oncol Ther |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42329588 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ermann+DA%22">Ermann DA</searchLink>; Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA. daniel.ermann@hci.utah.edu.<br /><searchLink fieldCode="AU" term="%22Stephens+DM%22">Stephens DM</searchLink>; University of North Carolina School of Medicine, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; BeOne Medicines, Ltd, San Carlos, CA, USA.<br /><searchLink fieldCode="AU" term="%22Varghese+I%22">Varghese I</searchLink>; ADVI Health, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22De+Souza+H%22">De Souza H</searchLink>; ADVI Health, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Sheetz+C%22">Sheetz C</searchLink>; ADVI Health, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Fu+Q%22">Fu Q</searchLink>; BeOne Medicines, Ltd, San Carlos, CA, USA.<br /><searchLink fieldCode="AU" term="%22Maglinte+GA%22">Maglinte GA</searchLink>; BeOne Medicines, Ltd, San Carlos, CA, USA.<br /><searchLink fieldCode="AU" term="%22Williams+R%22">Williams R</searchLink>; BeOne Medicines, Ltd, San Carlos, CA, USA.<br /><searchLink fieldCode="AU" term="%22Seymour+EK%22">Seymour EK</searchLink>; BeOne Medicines, Ltd, San Carlos, CA, USA.<br /><searchLink fieldCode="AU" term="%22van+Beuge+D%22">van Beuge D</searchLink>; BeOne Medicines, Ltd, San Carlos, CA, USA.<br /><searchLink fieldCode="AU" term="%22Shadman+M%22">Shadman M</searchLink>; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Jacobs+R%22">Jacobs R</searchLink>; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101677510%22">Oncology and therapy</searchLink> [Oncol Ther] 2026 Jun 22. <i>Date of Electronic Publication: </i>2026 Jun 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%22">Adis </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101677510 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2366-1089 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223661089%22">23661089 </searchLink><i>NLM ISO Abbreviation: </i>Oncol Ther |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42329588 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40487-026-00452-9 Languages: – Code: eng Text: English Titles: – TitleFull: Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ermann DA – PersonEntity: Name: NameFull: Stephens DM – PersonEntity: Name: NameFull: Wang X – PersonEntity: Name: NameFull: Varghese I – PersonEntity: Name: NameFull: De Souza H – PersonEntity: Name: NameFull: Sheetz C – PersonEntity: Name: NameFull: Fu Q – PersonEntity: Name: NameFull: Maglinte GA – PersonEntity: Name: NameFull: Williams R – PersonEntity: Name: NameFull: Seymour EK – PersonEntity: Name: NameFull: van Beuge D – PersonEntity: Name: NameFull: Shadman M – PersonEntity: Name: NameFull: Jacobs R IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 06 Text: 2026 Jun 22 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2366-1089 Titles: – TitleFull: Oncology and therapy Type: main |
| ResultId | 1 |
